$12.00

• Proven effective against SARS-CoV-2 on hard non-porous surfaces
• Effective against over 40 pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
• Compatible with most non-porous, hard surfaces commonly used in clinical settings
• 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis.

Fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim.